China, Sept. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter, Prospective, Observational, Real-World Registry Study of Cenobamate in the Treatment of Focal Epilepsy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131435
Registration Time: 2026/09/02
Type: Observational study
Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341189
Published by HT Digital Content Services with permission from Health Daily Digest....